


To provide capital growth and income.
| Name | % Net Assets |
|---|---|
| Vodafone Group PLC | 6.7% |
| GlaxoSmithKline PLC | 6.6% |
| Royal Dutch Shell PLC (CL B) | 6.0% |
| BP PLC | 5.1% |
| British American Tobacco PLC | 4.9% |
| AstraZeneca PLC | 4.7% |
| Imperial Tobacco Group PLC | 4.4% |
| National Grid PLC | 4.3% |
| BG Group PLC | 4.2% |
| HSBC Holdings PLC | 3.7% |
| Key | % Net Assets |
|---|---|
| 6.7% | |
| 6.6% | |
| 6.0% | |
| 5.1% | |
| 75.6% |
| Date | n/a |
|---|---|
| Bid | 0.00 |
| Offer | 0.00 |
| Currency | n/a |
| Change | 0.00 |
| % | n/a |
| YTD change | 0.00 |
| YTD % | n/a |
| Fund Inception | 13/02/2004 |
|---|---|
| Fund Manager | n/a |
| TER | - |
| Minimum Investment | |
|---|---|
| Initial | 500000 |
| Additional | n/a |
| Savings | n/a |
| Charges | |
|---|---|
| Initial | n/a |
| Annual Mang't | 2.00% |
| Exit | n/a |
| Name | % |
|---|---|
| Standard deviation | 0.01 |
| Sharpe ratio | 0.06 |
You are here: research